Perioperative outcomes of coronary artery bypass graft surgery in Johannesburg, South Africa.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
07 Jan 2021
Historique:
received: 17 07 2020
accepted: 09 12 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 6 5 2021
Statut: epublish

Résumé

The perioperative complications in patients with coronary artery disease undergoing coronary artery bypass graft (CABG) surgery have been reported predominantly from developed countries, with a paucity of data from sub-Saharan Africa. We aim to report on the clinical characteristics and perioperative complications in patients with obstructive coronary artery disease, managed with CABG surgery at a tertiary academic hospital in Johannesburg, South Africa. We retrospectively reviewed data from adult patients who underwent CABG surgery during a 17-year period (January 2000 - December 2017). Data was collected from the cardiothoracic surgery department's pre- and postoperative reports, the cardiology department's medical records, and anaesthesiology's intra-operative reports. We collected demographic, biochemical, clinical, surgical, echocardiographic, and angiographic data. Outcomes data collected included perioperative complications and mortality. We analysed 1218 consecutive patient records. The study cohort consisted of 951 (78.1%) males, and the mean age was 60.1 ± 10.1 years. During the study period, 137 (11.2%) patients demised with cardiac and sepsis-related causes of death accounting for 49.6 and 37.2%, respectively. Other perioperative complications included excessive bleeding in 222 (18.2%), prolonged ventilation (exceeding 48 h) in 139 (11.4%), and sternal sepsis in 125 (10.3%). On univariate logistic regression analysis, advanced age, a lower left ventricular ejection fraction, smoking, increased cardiopulmonary bypass (CPB) time, and a higher European System for Cardiac Operative Risk Evaluation (EuroSCORE) II were all significantly associated with mortality. The EuroSCORE II [OR: 0.15 95%CI: 0.09-0.22; p = 0.000], and prolonged CPB time [OR: 0.01 CI: 0.00-0.02; p = 0.000] were independent predictors of in-hospital all-cause mortality. In our study, the crude perioperative mortality rate was 11.2%. Our mortality rate was significantly higher than the mortality rates reported in other developed and developing countries. To better understand the factors driving this high mortality rate, a prospective outcomes registry has been initiated, and this promises to inform on our contemporary mortality and morbidity outcomes.

Sections du résumé

BACKGROUND BACKGROUND
The perioperative complications in patients with coronary artery disease undergoing coronary artery bypass graft (CABG) surgery have been reported predominantly from developed countries, with a paucity of data from sub-Saharan Africa. We aim to report on the clinical characteristics and perioperative complications in patients with obstructive coronary artery disease, managed with CABG surgery at a tertiary academic hospital in Johannesburg, South Africa.
METHODS METHODS
We retrospectively reviewed data from adult patients who underwent CABG surgery during a 17-year period (January 2000 - December 2017). Data was collected from the cardiothoracic surgery department's pre- and postoperative reports, the cardiology department's medical records, and anaesthesiology's intra-operative reports. We collected demographic, biochemical, clinical, surgical, echocardiographic, and angiographic data. Outcomes data collected included perioperative complications and mortality.
RESULTS RESULTS
We analysed 1218 consecutive patient records. The study cohort consisted of 951 (78.1%) males, and the mean age was 60.1 ± 10.1 years. During the study period, 137 (11.2%) patients demised with cardiac and sepsis-related causes of death accounting for 49.6 and 37.2%, respectively. Other perioperative complications included excessive bleeding in 222 (18.2%), prolonged ventilation (exceeding 48 h) in 139 (11.4%), and sternal sepsis in 125 (10.3%). On univariate logistic regression analysis, advanced age, a lower left ventricular ejection fraction, smoking, increased cardiopulmonary bypass (CPB) time, and a higher European System for Cardiac Operative Risk Evaluation (EuroSCORE) II were all significantly associated with mortality. The EuroSCORE II [OR: 0.15 95%CI: 0.09-0.22; p = 0.000], and prolonged CPB time [OR: 0.01 CI: 0.00-0.02; p = 0.000] were independent predictors of in-hospital all-cause mortality.
CONCLUSIONS CONCLUSIONS
In our study, the crude perioperative mortality rate was 11.2%. Our mortality rate was significantly higher than the mortality rates reported in other developed and developing countries. To better understand the factors driving this high mortality rate, a prospective outcomes registry has been initiated, and this promises to inform on our contemporary mortality and morbidity outcomes.

Identifiants

pubmed: 33413554
doi: 10.1186/s13019-020-01385-8
pii: 10.1186/s13019-020-01385-8
pmc: PMC7792285
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7

Références

Cardiovasc J Afr. 2013 Mar;24(2):34-42
pubmed: 23612951
Ann Thorac Surg. 2018 May;105(5):1419-1428
pubmed: 29577924
Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):488-494
pubmed: 31980397
Surg Res Pract. 2014;2014:726158
pubmed: 25374960
J Cardiovasc Thorac Res. 2011;3(2):53-6
pubmed: 24250953
J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2703-2708
pubmed: 31084990
Rev Bras Cir Cardiovasc. 2014 Oct-Dec;29(4):513-20
pubmed: 25714203
J Thorac Cardiovasc Surg. 2018 Mar;155(3):875-882.e1
pubmed: 29248284
Int J Cardiol. 2017 Mar 1;230:175-180
pubmed: 28062147
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
BMC Med. 2019 Nov 26;17(1):209
pubmed: 31767015
Ann Thorac Surg. 2018 May;105(5):1411-1418
pubmed: 29577925
Lancet. 2019 Aug 24;394(10199):685-696
pubmed: 31448740
Ann Thorac Surg. 2010 May;89(5):1502-9
pubmed: 20417768
J Cardiovasc Surg (Torino). 2019 Jun;60(3):396-405
pubmed: 30916532
Cardiovasc J Afr. 2016 May/Jun;27(3):170-176
pubmed: 27841902
Interact Cardiovasc Thorac Surg. 2019 Oct 1;29(4):568-575
pubmed: 31230080
Chest. 1997 Sep;112(3):666-75
pubmed: 9315799
JAMA. 2004 Jan 14;291(2):195-201
pubmed: 14722145
Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13
pubmed: 10456395
N Engl J Med. 2002 Apr 11;346(15):1128-37
pubmed: 11948273
Br J Anaesth. 2018 Mar;120(3):509-516
pubmed: 29452807
Ann Thorac Surg. 2016 Oct;102(4):1296-303
pubmed: 27319983
Clin Cardiol. 2012 May;35(5):297-300
pubmed: 22362298

Auteurs

Samantha Reiche (S)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, 17 Jubilee Road, Parktown, Johannesburg, 2193, South Africa.

Dineo Mpanya (D)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, 17 Jubilee Road, Parktown, Johannesburg, 2193, South Africa.

Katharina Vanderdonck (K)

Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand and the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Shungu Mogaladi (S)

Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand and the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Palesa Motshabi-Chakane (P)

Department of Anaesthesiology, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand and the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Nqoba Tsabedze (N)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, 17 Jubilee Road, Parktown, Johannesburg, 2193, South Africa. Nqoba.Tsabedze@wits.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH